![Patrick Malloy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Patrick Malloy is currently the Senior Vice President-Investor Relations at Abivax SA since 2023.
Prior to this, he worked as the VP-Investor Relations & Corporate Communications at Arena Pharmaceuticals, Inc. and as the SVP-Investor Relations & Strategic Communications at VectivBio Holding AG.
Aktive Positionen von Patrick Malloy
| Unternehmen | Position | Beginn |
|---|---|---|
| ABIVAX | Investor Relations Kontakt | 23.08.2023 |
Ehemalige bekannte Positionen von Patrick Malloy
| Unternehmen | Position | Ende |
|---|---|---|
| VECTIVBIO HOLDING AG | Investor Relations Kontakt | - |
| ARENA PHARMACEUTICALS | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
